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In developed countries chronic disease is currently the main reason why people demand health care A cross‐sectional design was developed based on a random sample of 141 patients with pathologies
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[1]. Negative effects of non‐compliance with medical prescription reduce the clinical benefits of the
medication, leading in most cases to the use of unnecessary treatments, hospitalization and death
[2]. Factors associated with non‐compliance with medical prescription may be related to: the doctor‐
patient relationship, the treatment, the health system, the health condition and the socioeconomic
situation.
To assess the impact of the doctor‐patient relationship on non‐compliance with pharmacological medical prescription in chronic disease.
covered by Portuguese Exceptional Legislation. To collect the data, it was applied a questionnaire by
interview between July 2017 and April 2018. The questionnaire included socioeconomic variables and a
list of non‐compliance factors developed by Cabral & Silva (2010) [3]. The IBM SPSS 24.0 software was
used to analyse the data. Besides descriptive statistics, the data analysis involved the estimation of a
logistic regression model, at a confidence level of 95%.
Chronic patients were aged between 20 and 95 years old, with a mean age of 65.3 years (SD = 19.39). As shown in Figure 1, most patients were female (51.8%), married or lived in marital cohabitation (62.4%)
(Figure 2), retired (55.3%) (Figure 3), and had up to the 3rd cycle of schooling (61%) (Figure 4) and an income up to € 1,000 (62.5%) (Figures 5). These patients suffered from Chronic Renal Insufficiency (CRI)
(n=89), Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PA) (n=29), Multiple Sclerosis (MS) (n=15), Amyotrophic Lateral Sclerosis (ALS) (n=3), Hepatitis C Virus (HCV) (n=3), Hepatic disease (HD) (n=1)) and
Gaucher Syndrome (GS) (n=1) (Figure 6). The active substances most dispensed, in hospital pharmacy, were: ferrous sulphate (76.6%), folic acid (73.8%), calcium polysterenonosulfonate (53.2%), alfacalcidol
































































































































































































































The main reason for non‐compliance with pharmacological prescription was “the doctor prescribes too many medications”
(35%). The second most mentioned reason was “the fear to ask questions”(18.4%), followed by "not realize what doctors say"
(17.5%) and the “lack of confidence in doctors” (6.8%) (Figure 8). Over 30% of patients do not always follow therapy as
prescribed by their doctor (37.6%) (Figure 7). A patient who does not consider that “the doctor prescribes too many
medications” has a lower risk of non‐compliance with the pharmacological prescription [OR= 0,262; CI (95%): 0,112‐0,617]
Dependent variable: Medical prescripton compliance [Y=0, No (37.6%); Y=1, Yes (62.4%)]
Variables β Standard deviation Significance Exp (B)/OR CI(95%)
Constant




















The doctor‐patient relationship is fundamental for compliance with the prescribed therapy and consequently for the improvement of the clinical benefits of medication and well‐being
of the patient.
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